Taisho Pharmaceutical Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Taisho Pharmaceutical Holdings has a total shareholder equity of ¥857.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1,005.5B and ¥148.2B respectively. Taisho Pharmaceutical Holdings's EBIT is ¥18.9B making its interest coverage ratio -4. It has cash and short-term investments of ¥266.4B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -4x |
Cash | JP¥266.37b |
Equity | JP¥857.30b |
Total liabilities | JP¥148.17b |
Total assets | JP¥1.01t |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TAIP.Y's short term assets (¥416.8B) exceed its short term liabilities (¥80.8B).
Long Term Liabilities: TAIP.Y's short term assets (¥416.8B) exceed its long term liabilities (¥67.3B).
Debt to Equity History and Analysis
Debt Level: TAIP.Y is debt free.
Reducing Debt: TAIP.Y has not had any debt for past 5 years.
Debt Coverage: TAIP.Y has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TAIP.Y has no debt, therefore coverage of interest payments is not a concern.